Skip to content
Home/Companies/Biotech/Compass Pathways
CP

Compass Pathways

Biotech·United Kingdom·Exited 2020·Held 2yr

Compass Pathways is a biotech company, headquartered in United Kingdom.

Entry
2018
Hold
2yr
Exit
2020
Est. EV
–

Who owns Compass Pathways?

Compass Pathways was owned by Principia SGR through Principia III - Health (2014 vintage) from 2018 to 2020, exited via IPO.

Hand-verified · updated 2026-07-26

Principia SGR
Investor
Principia SGR
Principia III - Health · 2014 · Life Sciences VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2020

More from Principia III - Health

Other portfolio companies in the same fund.

Comftech
Active
MedTechItaly· 2018
CrestOptics
Active
MedTechItaly· 2018
Enterome
Active
BiotechFrance· 2018
Gada
Active
MedTechItaly· 2018
Trifarma
Active
PharmaItaly· 2017
AnaBios
Active
BiotechUnited States· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings